73 results
8-K
EX-99.1
VXRT
Vaxart Inc
30 Apr 24
Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers
4:22pm
developing. Passive transfer of antibodies from mothers to infants via breast milk is an innovative approach to potentially improve infection resistance
8-K
VXRT
Vaxart Inc
6 Mar 24
Vaxart, Inc. Appoints Steven Lo as New President, Chief Executive Officer, and Director
9:23am
and commercialization of innovative products to enhance cancer care. At that company, he built and led business development and the worldwide commercialization
8-K
EX-99.1
ajqq32u
6 Mar 24
Vaxart, Inc. Appoints Steven Lo as New President, Chief Executive Officer, and Director
9:23am
8-K
EX-99.1
1oivkf4l58fowo2rnc
19 Jan 24
Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
5:14pm
8-K
EX-99.1
xoen1nwzattc6 po2bi
9 May 23
Vaxart Provides Business Update and Reports First Quarter 2023 Financial Results
4:57pm
8-K
EX-99.1
d6a diob0w
28 Jun 22
Other Events
5:09pm
8-K
EX-99.1
diw4xr8p g93sfb6v
15 Feb 22
Vaxart Appoints Edward Berg as Senior Vice President and General Counsel
4:02pm
8-K
EX-99.1
0lep tkn7
23 Apr 21
Vaxart Appoints David Wheadon, M.D., to its Board of Directors
4:00pm
8-K
EX-99.1
zpdk3e97wkmiz
27 Aug 20
Vaxart Appoints Karen J. Wilson to its Board of Directors
8:09am